cic: patient uic yyyy - mm - dd hsct - minimum essential ... · cic: hospital upn: hsct date: yyyy...

Download CIC: Patient UIC yyyy - mm - dd HSCT - Minimum Essential ... · CIC: Hospital UPN: HSCT Date: yyyy - mm - dd Patient UIC Status At HSCT Adjuvant Never treated (upfront) Stable disease/no

If you can't read please download the document

Upload: others

Post on 10-Sep-2019

13 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

Infections in HSCT

(MM/DD/YYYY) (MM/DD/YYYY) - nyc.gov

Population and Geographic Data Section Division of ... · yyyy y yyyyyyyy yyyyyyyyyyyyy yyyy y yyyyyyyyyyyyy yyyy yyyyyyy yyyyyy ##### # ### yyyy yyyyyyy yyyyyy yyyy y yyyyyyyyyyyyyyyyyyyy

HSCT for Pediatric Lymphoma

Ellsworth LeDrew (UIC) Gary Foley (UIC) Jay Pearlman (UIC and ADC) Hans-Peter Plag (UIC and ADC) Rudolf Husar (UIC and ADC) David McCabe (ADC)

Transfusion in hsct

BK Virus infection in HSCT

Managing MF and SS with Allogeneic HSCT - Cutaneous …cutaneouslymphoma.stanford.edu/documents/SY58 allo HSCT in MFSS… · Managing MF and SS with Allogeneic HSCT Youn H Kim, MD

CIC: Patient UIC yyyy - mm - dd HSCT - Minimum Essential Data - A · 2020-06-15 · Chronic Myeloid Leukaemia (CML) Chronic Lymphocytic Leukaemia (CLL) Lymphoma ... CYTOGENETICS REMISSION

DD/MM/YYYY DD/MM/YYYY

Radioimmuntherapie zur Myeloablation vor HSCT bei Kindern

CIC: Patient UIC yyyy - mm - dd HSCT - Minimum Essential ... · Centre Identification Patient Data Primary Disease Diagnosis Sex: PRIMARY DISEASE DIAGNOSIS EBMT Code yyyy - mm - dd

UIC Global Signalling & Telecom conference · UIC GSM-R Operators Group Chairman/SYSTRA Consultant Director ... UIC Global Signalling & Telecom conference UIC Global Signalling

(mm, yyyy) (mm, yyyy - mm, yyyy) Lic. Lidia Rosa Rivero

Marché - consultants HSCT

Allogeneic HSCT for Myelodysplastic Syndromes and ... · myelodysplastic syndromes and myeloproliferative ... 3.2 Polycythemia ... Allogeneic HSCT for Myelodysplastic Syndromes and

Benjamin W. Fischer-Valuck, MD,yyyy Anupama Chundury, MD,yyyy Hiram Gay, MD, yyyy Walter Bosch, DSc, yyyy and Jeff Michalski, MD, MBA yyyy *Texas Oncology, Texas Center for Proton

CIC: Patient UIC yyyy - mm - dd HSCT - Minimum Essential Data - A · 2018. 2. 21. · Antiphospholipid syndrome Other type of connective tissue disease, specify:_____ Classification:

CIC: Patient UIC yyyy - mm - dd HSCT - Minimum Essential ... Hodgkin Lymp… · REGISTRATION: HISTORY UP TO HS T – SELE TED - ELL LYMPHOMAS Selected B-Cell Non Hodgkin Lymphomas

Lab tests in HSCT

UIC APPLICATIONS: UIC-14s,UIC-17s, UIC-P&As,UIC-32s, and UIC-WH1s

2019: Waldenstrom's Macroglobulinemia Pre- HSCT Data

Koleje Mazowieckie · 2018. 8. 1. · UIC 520 UIC 521 I ed c.a, UIC 533 UIC 534 czeó 1987 4 edycja, sierpieá 2002 UIC 540 5edycja, listopad 2006 UIC 541-1 6 ed c.a, listo ad 2003

Séminaire HSCT

INTRODUCTION TO HAEMATOPOIETIC STEM CELL TRANSPLANT(HSCT)

REQUEST FOR CONSULTING SERVICES - … · Web viewBOR/SBC Authority to Construct: Month YYYY Bid Date: Month YYYY Start Construction: Month YYYY Substantial Completion: Month YYYY

CIC: Patient UIC yyyy - mm - dd HSCT - Minimum Essential

New patient packet w policiesHepatitis A MM /YYYY A MM Measles /YYYY A MM Tetanus 1 MM YYYY Chicken Pox /YYYY A Hepatitis B MM /YYYY A Flu2 MM /YYYY A MM Pneumonia 3 MM /YYYY A Meningococcal

Patient UIC HSCT - Minimum Essential Data - A...Patient UIC Other, specify: _____ Chronological number of the cell infusion episode for this patient _____ Acute Graft Versus Host Disease

CIC: Patient UIC yyyy - mm - dd HSCT - Minimum Essential Data - A · 2018-02-21 · Risk Factors/Staging at Diagnosis Histological classification Gonadal Disease SOLID TUMOURS (main

UIC - Telecharger - Home | UIC

Introduction to Haematopoietic Stem Cell Transplantation (HSCT) Covenant Health System HSCT Program Lubbock, Texas April 4, 2007

Allo -HSCT for ALL

Code UIC 2019 - UIC-Kodex 2019 - UIC Code 2019 · 2019-08-09 · Code UIC Catalogue des Fiches UIC et IRS UIC-Kodex Katalog der UIC-Merkblätter und IRS UIC Code Catalogue of UIC

Pharmacokinetics and Pharmacodynamics of Posaconazole · AML/MDS Allogeneic HSCT SICU AML/MDS HV,IMD (48%HSCT) HM HV,AML/MDS/ HSCT IMD HV,AML/MDS/ HSCT,clinical trials Numberofindi-215